Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

During the Trading Day
115.99 -3.28 / -2.75%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
115.99 0.00 / 0.00%
 
Volume: 1.8K

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 131.00, with a high estimate of 163.00 and a low estimate of 110.00. The median estimate represents a +12.94% increase from the last price of 115.99.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.09
Sales
$65.1M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -32.86%
 
 
 
 
 
 
Growthannually 491.03%
 
 
 
 
 
 

Sales

Growthquarterly 5.36%
 
 
 
 
 
 
Growthannually 68.05%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account